Literature DB >> 24777109

"TRIMing" the patient population to increase the benefit of mTOR inhibition.

H Ian Robins1, Mark E Burkard1, Richard B Halberg2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24777109     DOI： 10.1093/jnci/dju095

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.

Authors:  Ying Xing; Qingwei Meng; Xuesong Chen; Yanbin Zhao; Wei Liu; Jing Hu; Feng Xue; Xiaoyuan Wang; Li Cai
Journal:  Oncotarget       Date:  2016-05-24

2.  Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.

Authors:  Xiao-Yu Jiang; Fei-Fei Guan; Jia-Xin Ma; Wei Dong; Xiao-Long Qi; Xu Zhang; Wei Chen; Shan Gao; Xiang Gao; Shuo Pan; Ji-Zheng Wang; Yuan-Wu Ma; Lian-Feng Zhang; Dan Lu
Journal:  Dis Model Mech       Date:  2022-08-18       Impact factor: 5.732
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.